CNS vs GATX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CNS

55.5
AI Score
VS
CNS Wins

GATX

52.3
AI Score

Investment Advisor Scores

CNS

56score
Recommendation
HOLD

GATX

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS GATX Winner
Revenue 1.16B 94.41M GATX
Net Income 188.90M 29.96M GATX
Net Margin 16.2% 31.7% CNS
ROE 6.8% 9.9% CNS
ROA 1.1% 6.7% CNS
Total Assets 17.72B 450.12M GATX
Cash 747.10M 193.73M GATX

Relative Price Performance (Last 90 Days)

CNS 1M: +6.3% · 3M: +17.0% GATX 1M: +4.2% · 3M: -8.7%

Current Technical Phase

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 60

RSI (14): 60.3 · Price: $82.27

GATX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.0%) with fading momentum, RSI 48

RSI (14): 48.4 · Price: $178.87

Fundamentals Snapshot

Metric CNS GATX
Market Cap
Forward P/E 21.2 16.0
Trailing P/E 25.1 19.5
Revenue (TTM)
Revenue Growth 0.1% 0.4%
Gross Margin 0.5% 0.7%
Operating Margin 0.3% 0.3%
EPS 3.25 9.32
Dividend Yield 0.03% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.